Federated Hermes, Inc. Aptinyx Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $2.58 $56 - $381	-148 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$1.81 - $5.03 $430 - $1,197	-238 Reduced 61.66%	148 $1,000
Q4 2019 Feb 14, 2020	SELL	$2.84 - $4.25 $2,601 - $3,893	-916 Reduced 70.35%	386 $1,000
Q3 2019 Nov 14, 2019	SELL	$3.0 - $4.08 $6,294 - $8,559	-2,098 Reduced 61.71%	1,302 $5,000
Q2 2019 Aug 14, 2019	BUY	$2.95 - $4.38 $10,030 - $14,892	3,400 New	3,400 $11,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.